Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know?

References

• Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth 2009;9:8
   PubMed Web of Science ®Google Scholar
• Egerman RS, Sibai BM. HELLP syndrome. Clin Obstet Gynecol 1999;42:381–9
   PubMed Web of Science ®Google Scholar
• Kappler S, Ronan-Bentle S, Graham A. Thrombotic microangiopathies (TTP, HUS, HELLP). Emerg Med Clin North Am 2014;32:649–71
   PubMed Web of Science ®Google Scholar
• Pijnenborg R, Vercruysse L, Hanssens M, Brosens I. Endovascular trophoblast and preeclampsia: a reassessment. Pregnancy Hypertens 2011;1:66–71
   PubMed Web of Science ®Google Scholar
• van Dam PA, Renier M, Baekelandt M, et al. Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia. Obstet Gynecol 1989;73:97–102
   PubMed Web of Science ®Google Scholar
• Osmanagaoglu MA, Osmanagaoglu S, Ulusoy H, Bozkaya H. Maternal outcome in HELLP syndrome requiring intensive care management in a Turkish hospital. Sao Paulo Med J 2006;124:85–9
   PubMedGoogle Scholar
• Haddad B, Barton JR, Livingston JC, et al. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000;183:444–8
   PubMed Web of Science ®Google Scholar
• Sibai BM, Taslimi MM, el-Nazer A, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501–9
   PubMed Web of Science ®Google Scholar
• Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000–6
   PubMed Web of Science ®Google Scholar
• Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460–4
   PubMed Web of Science ®Google Scholar
• Deruelle P, Coudoux E, Ego A, et al. Risk factors for post-partum complications occurring after preeclampsia and HELLP syndrome. A study in 453 consecutive pregnancies. Eur J Obstet Gynecol Reprod Biol 2006;125:59–65
   PubMed Web of Science ®Google Scholar
• Visser W, Wallenburg HC. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:111–7
   PubMedGoogle Scholar
• Rattray DD, O’Connell CM, Baskett TF. Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can 2012;34:341–7
   PubMedGoogle Scholar
• Erez O, Novack L, Beer-Weisel R, et al. DIC score in pregnant women – a population based modification of the International Society on Thrombosis and Hemostasis score. PLoS One 2014;9:e93240
   PubMed Web of Science ®Google Scholar
• Letsky EA. Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 2001;15:623–44
   PubMed Web of Science ®Google Scholar
• Bick RL. Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology. Objective criteria for diagnosis and management. Hematol Oncol Clin North Am 2000;14:999–1044
   PubMed Web of Science ®Google Scholar
• Naz H, Fawad A, Islam A, et al. Disseminated intravascular coagulation. J Ayub Med Coll Abbottabad 2011;23:111–3
   PubMedGoogle Scholar
• Kor-Anantakul O, Lekhakula A. Overt disseminated intravascular coagulation in obstetric patients. J Med Assoc Thai 2007;90:857–64
   PubMedGoogle Scholar
• Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol 2015;213:452–63
   PubMed Web of Science ®Google Scholar
• Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006;108:1005–16
   PubMed Web of Science ®Google Scholar
• Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand 2011;90:140–9
   PubMed Web of Science ®Google Scholar
• Haram K, Bergsjø P, Ulstein M. Antepartum hemorrhage. In: Iffy L, Apuzzio JJ, V entzileos AM, eds. Operative obstetrics. 2nd ed. New York: McGraw-Hill, INC; 1992:281–97
   Google Scholar
• Nilsen PA. The mechanism of hypofibrinogenemia in premature separation of the normally implanted placena. Acta Obstet Gynecol Scand 1963;42:1–96
   PubMedGoogle Scholar
• Strand S, Strand D, Seufert R, et al. Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome. Gastroenterology 2004;126:849–58
   PubMed Web of Science ®Google Scholar
• Barton JR, Riely CA, Adamec TA, et al. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 1992;167:1538–43
   PubMed Web of Science ®Google Scholar
• Rolfes DB, Ishak KG. Liver disease in toxemia of pregnancy. Am J Gastroenterol 1986;81:1138–44
   PubMed Web of Science ®Google Scholar
• August P, Murthi V, Laragh J, Druzin M, Suthanthiran M. Intracellular free calcium in lymphocytes of normal and hypertensive pregnancies. In: Cosmi EV, Renzo GC, eds. Proceedings of the Seventh World Congress of Hypertension in Pregnancy. New York: The Congress; 1990:263
   Google Scholar
• Oian P, Omsjø I, Maltau JM, Osterud B. Increased sensitivity to thromboplastin synthesis in blood monocytes from pre-eclamptic patients. Br J Obstet Gynaecol 1985;92:511–7
   PubMedGoogle Scholar
• Barden A, Graham D, Beilin LJ, et al. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin Sci (Lond) 1997;92:37–44
   PubMed Web of Science ®Google Scholar
• Vince GS, Starkey PM, Austgulen R, et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995;102:20–5
   PubMedGoogle Scholar
• Perry KG, Martin JN. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynecol 1992;35:338–50
   PubMed Web of Science ®Google Scholar
• Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80–6
   PubMed Web of Science ®Google Scholar
• Gervasi MT, Chaiworapongsa T, Pacora P, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol 2001;185:792–7
   PubMed Web of Science ®Google Scholar
• Evsen MS, Kalkanli S, Deveci E, et al. Human placental macrophages (Hofbauer cells) in severe preeclampsia complicated by HELLP syndrome: immunohistochemistry of chorionic villi. Anal Quant Cytopathol Histpathol 2013;35:283–8
   PubMed Web of Science ®Google Scholar
• de Boer K, Büller HR, ten Cate JW, Treffers PE. Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets. Br J Obstet Gynaecol 1991;98:42–7
   PubMedGoogle Scholar
• Paternoster DM, Stella A, Simioni P, et al. Coagulation and plasma fibronectin parameters in HELLP syndrome. Int J Gynaecol Obstet 1995;50:263–8
   PubMed Web of Science ®Google Scholar
• Kolben M, Lopens A, Schmitt M, et al. [Changes in fibrinolysis-associated parameters in HELLP syndrome]. Geburtshilfe Frauenheilkd 1994;54:257–61
   PubMed Web of Science ®Google Scholar
• Guven S, Sonmez M, Karahan SC. The role of fibrinolytic and antifibrinolytic activities in the pathophysiology of HELLP syndrome. Hypertens Pregnancy 2011;30:275–86
   PubMed Web of Science ®Google Scholar
• Lurie S, Feinstein M, Mamet Y. Disseminated intravascular coagulopathy in pregnancy: thorough comprehension of etiology and management reduces obstetricians’ stress. Arch Gynecol Obstet 2000;263:126–30
   PubMed Web of Science ®Google Scholar
• Asakura H, Wada H, Okamoto K, et al. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections. Thromb Haemost 2006;95:282–7
   PubMed Web of Science ®Google Scholar
• Joly B, Barbay V, Borg JY, Le Cam-Duchez V. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies. Thromb Res 2013;132:386–91
   PubMed Web of Science ®Google Scholar
• Wada H, Minamikawa K, Wakita Y, et al. Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 1993;43:190–4
   PubMed Web of Science ®Google Scholar
• Szecsi PB, Jørgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010;103:718–27
   PubMed Web of Science ®Google Scholar
• Francalanci I, Comeglio P, Liotta AA, et al. D-dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res 1995;78:399–405
   PubMed Web of Science ®Google Scholar
• Morse M. Establishing a normal range for D-dimer levels through pregnancy to aid in the diagnosis of pulmonary embolism and deep vein thrombosis. J Thromb Haemost 2004;2:1202–4
   PubMed Web of Science ®Google Scholar
• Réger B, Péterfalvi A, Litter I, et al. Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women. Thromb Res 2013;131:e183–7
   PubMed Web of Science ®Google Scholar
• Chabloz P, Reber G, Boehlen F, et al. TAFI antigen and D-dimer levels during normal pregnancy and at delivery. Br J Haematol 2001;115:150–2
   PubMed Web of Science ®Google Scholar
• Giavarina D, Mezzena G, Dorizzi RM, Soffiati G. Reference interval of D-dimer in pregnant women. Clin Biochem 2001;34:331–3
   PubMed Web of Science ®Google Scholar
• Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem 2005;51:825–9
   PubMed Web of Science ®Google Scholar
• Kovac M, Mikovic Z, Rakicevic L, et al. The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy. Eur J Obstet Gynecol Reprod Biol 2010;148:27–30
   PubMed Web of Science ®Google Scholar
• Kristoffersen AH, Petersen PH, Sandberg S. A model for calculating the within-subject biological variation and likelihood ratios for analytes with a time-dependent change in concentrations; exemplified with the use of D-dimer in suspected venous thromboembolism in healthy pregnant women. Ann Clin Biochem 2012;49:561–9
   PubMed Web of Science ®Google Scholar
• Yamada T, Kawaguchi S, Araki N, et al. Difference in the D-dimer rise between women with singleton and multifetal pregnancies. Thromb Res 2013;131:493–6
   PubMed Web of Science ®Google Scholar
• Bergmann F, Pingel N, Czwalinna A, Koch M. D-Dimer in normal pregnancy: determination of reference values for three commercially available assays. Clin Chem Lab Med 2014;52:e257–9
   PubMed Web of Science ®Google Scholar
• Brill-Edwards P, Lee A. D-dimer testing in the diagnosis of acute venous thromboembolism. Thromb Haemost 1999;82:688–94
   PubMed Web of Science ®Google Scholar
• Lehman CM, Wilson LW, Rodgers GM. Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation. Am J Clin Pathol 2004;122:178–84
   PubMed Web of Science ®Google Scholar
• Favaloro EJ. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost 2010;36:458–67
   PubMed Web of Science ®Google Scholar
• Levi M, Meijers JC. DIC: which laboratory tests are most useful. Blood Rev 2011;25:33–7
   PubMed Web of Science ®Google Scholar
• Verduzco Rodríguez L, González Puebla E, Manffrini Madrid F, López Ariza B. [D-dimer in different stages of pregnancy toxemia. A pilot study]. Ginecol Obstet Mex 1998;66:77–80
   PubMedGoogle Scholar
• Belowska A, Ulman-Włodarz I, Galbierz-Kwiatkowska E. [Pregnancy complicated by HELLP syndrome]. Wiad Lek 2004;57:17–20
   PubMedGoogle Scholar
• Levi M, de Jonge E, van der Poll T, ten Cate H. Disseminated intravascular coagulation. Thromb Haemost 1999;82:695–705
   PubMed Web of Science ®Google Scholar
• Hellgren M, Egberg N, Eklund J. Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients. Intensive Care Med 1984;10:23–8
   PubMed Web of Science ®Google Scholar
• Taylor FB, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327–30
   PubMed Web of Science ®Google Scholar
• Windsperger K, Lehner R. The fibrinogen/CRP ratio as a new parameter for the diagnosis of disseminated intravascular coagulation in patients with HELLP syndrome and as a predictive factor for neonatal outcome. Am J Obstet Gynecol 2013;208:118.e111–7
   Google Scholar
• Martin JN, Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999;180:1373–84
   PubMed Web of Science ®Google Scholar
• Yu M, Nardella A, Pechet L. Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis. Crit Care Med 2000;28:1777–80
   PubMed Web of Science ®Google Scholar
• Magann EF, Martin JN. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 1999;42:532–50
   PubMed Web of Science ®Google Scholar
• Gando S, Iba T, Eguchi Y, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med 2006;34:625–31
   PubMed Web of Science ®Google Scholar
• Terao T, Maki M, Ikenoue T. A prospective study in 38 patients with abruptio placentae of 70 cases complicated by DIC. Asia Oceania J Obstet Gynaecol 1987;13:1–13
   PubMedGoogle Scholar
• Kumar R, Gupta V. Disseminated intravascular coagulation: current concepts. Indian J Pediatr 2008;75:733–8
   PubMed Web of Science ®Google Scholar
• Sharma P, Saxena R. A novel thromboelastographic score to identify overt disseminated intravascular coagulation resulting in a hypocoagulable state. Am J Clin Pathol 2010;134:97–102
   PubMed Web of Science ®Google Scholar
• Mallaiah S, Barclay P, Harrod I, et al. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015;70:166–75
   PubMed Web of Science ®Google Scholar
• Merchant SH, Mathew P, Vanderjagt TJ, et al. Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancy. Obstet Gynecol 2004;103:1055–8
   PubMed Web of Science ®Google Scholar
• Dart BW, Cockerham WT, Torres C, et al. A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome. J Trauma 2004;57:171–4
   PubMedGoogle Scholar
• van de Minkelis JL, Steenvoorde P, Baranski AG. Liver rupture in a patient with HELLP syndrome successfully treated with extensive surgery combined with recombinant factor VIIa. Acta Chir Belg 2006;106:602–4
   PubMed Web of Science ®Google Scholar
• Detti L, Mecacci F, Piccioli A, et al. Postpartum heparin therapy for patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) is associated with significant hemorrhagic complications. J Perinatol 2005;25:236–40
   PubMedGoogle Scholar
• Paternoster DM, Fantinato S, Manganelli F, et al. Recent progress in the therapeutic management of pre-eclampsia. Expert Opin Pharmacother 2004;5:2233–9
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Terao T, Maki M, Ikenoue T. Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 2001;27:161–7
   PubMed Web of Science ®Google Scholar
• Maruyama I. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation. Thromb Haemost 1999;82:718–21
   PubMed Web of Science ®Google Scholar
• Kawano N, Tasaki A, Kuriyama T, et al. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution – an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases. Intern Med 2014;53:205–13
   PubMed Web of Science ®Google Scholar
• O’Brien JM, Barton JR. Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 2005;48:460–77
   PubMed Web of Science ®Google Scholar